Your browser doesn't support javascript.
loading
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Vernieri, Claudio; Nichetti, Federico; Lalli, Luca; Moscetti, Luca; Giorgi, Carlo Alberto; Griguolo, Gaia; Marra, Antonio; Randon, Giovanni; Rea, Carmen G; Ligorio, Francesca; Scagnoli, Simone; De Angelis, Claudia; Molinelli, Chiara; Fabbri, Agnese; Ferraro, Emanuela; Trapani, Dario; Milani, Andrea; Agostinetto, Elisa; Bernocchi, Ottavia; Catania, Giovanna; Vantaggiato, Amelia; Palleschi, Michela; Moretti, Anna; Basile, Debora; Cinausero, Marika; Ajazi, Arta; Castagnoli, Lorenzo; Lo Vullo, Salvatore; Gerratana, Lorenzo; Puglisi, Fabio; La Verde, Nicla; Arpino, Grazia; Rocca, Andrea; Ciccarese, Mariangela; Pedersini, Rebecca; Fabi, Alessandra; Generali, Daniele; Losurdo, Agnese; Montemurro, Filippo; Curigliano, Giuseppe; Del Mastro, Lucia; Michelotti, Andrea; Cortesi, Enrico; Guarneri, Valentina; Pruneri, Giancarlo; Mariani, Luigi; de Braud, Filippo.
Afiliação
  • Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. claudio.vernieri@istitutotumori.mi.it.
  • Nichetti F; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Lalli L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Moscetti L; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Giorgi CA; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Griguolo G; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Marra A; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Randon G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
  • Rea CG; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Ligorio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Scagnoli S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Angelis C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Molinelli C; Department of Medico-Surgical Sciences and Translational Medicine, "Sapienza" University of Rome, Rome, Italy.
  • Fabbri A; UO Oncologia Medica 2, Ospedale S. Chiara, Dipartimento di Oncologia, Dei Trapianti e Delle Nuove Tecnologie, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
  • Ferraro E; IRCCS Ospedale Policlinico San Martino, U.O.S.D. Breast Unit, Genova, Italy.
  • Trapani D; Medical Oncology Unit, Belcolle Hospital, Viterbo, Italy.
  • Milani A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Agostinetto E; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Bernocchi O; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Catania G; Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
  • Vantaggiato A; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Palleschi M; Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Moretti A; Medical Oncology & Breast Unit, "Vito Fazzi" Hospital, Lecce, Italy.
  • Basile D; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST, Meldola, Italy.
  • Cinausero M; Department of Oncology, ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy.
  • Ajazi A; Department of Medical Oncology, IRCCS Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy.
  • Castagnoli L; Department of Oncology, ASUFC University Hospital of Udine, Udine, Italy.
  • Lo Vullo S; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Gerratana L; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Puglisi F; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • La Verde N; Department of Medical Oncology, IRCCS Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy.
  • Arpino G; Department of Medicine, University of Udine, Udine, Italy.
  • Rocca A; Department of Medical Oncology, IRCCS Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy.
  • Ciccarese M; Department of Medicine, University of Udine, Udine, Italy.
  • Pedersini R; Department of Oncology, ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy.
  • Fabi A; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Generali D; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST, Meldola, Italy.
  • Losurdo A; Medical Oncology & Breast Unit, "Vito Fazzi" Hospital, Lecce, Italy.
  • Montemurro F; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy.
  • Curigliano G; Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Del Mastro L; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Michelotti A; Breast Cancer Unit & Translational Research Unit, ASST Cremona, Cremona, Italy.
  • Cortesi E; Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
  • Guarneri V; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Pruneri G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Mariani L; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • de Braud F; IRCCS Ospedale Policlinico San Martino, U.O.S.D. Breast Unit, Genova, Italy.
Clin Cancer Res ; 27(12): 3443-3455, 2021 06 15.
Article em En | MEDLINE | ID: mdl-33785482
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Everolimo Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Everolimo Idioma: En Ano de publicação: 2021 Tipo de documento: Article